News
01-20-2022, 07:13 PM
A study by researchers at Mayo Clinic Cancer Center has found that patients with cancer who receive chemotherapy - and some targeted therapies, such as CDK4/6 inhibitors and therapies targeted at B cells - may mount an inadequate immune response to COVID-19 vaccination.
More... (https://www.news-medical.net/news/20220120/Cancer-patients-receiving-treatment-may-mount-inadequate-immune-response-to-COVID-19-vaccination.aspx)
More... (https://www.news-medical.net/news/20220120/Cancer-patients-receiving-treatment-may-mount-inadequate-immune-response-to-COVID-19-vaccination.aspx)